Innovative Medical Research has been conducting clinical trials since 1996 and was incorporated in 1999. IMR has treated hundreds of patients and completed over 200 trials, participating in Phases I, II, III, and IV clinical trials. IMR is a fully-staffed clinical trial site consisting of study coordinators, a full-time Regulatory Director, a Principle Investigator and Sub-Investigators.IMR began as an Oncology/Hematology clinical trial center. IMR’s success in the treatment and administration of these studies lead them to expand further, not only in the number of conditions for which they conducted trials, but also to become a Multi-Specialty clinical trials center and Medical Device trial center.
This study is to evaluate the safety and tolerability of single or multiple doses of the investigational drug KAN-101 subjects with confirmed celiac disease.Click To Learn More
This study is to evaluate the efficacy and safety of Mirikizumab in patients with moderately to severely active Crohn's Disease.Click To Learn More
This study is to Evaluate safety, tolerability and efficacy of PN-943 treatment in subjects with moderate to severe active ulcerative colitis compared to placebo.Click To Learn More
This study is to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473, an orally administered drug, in patients with moderate-to-severe active Ulcerative Colitis (UC).Click To Learn More
This study is to evaluate the efficacy and safety of induction therapy with 2 doses of TD-1473 in patients with moderate-to-severe active Crohn’s Disease (CD).Click To Learn More